FISCHERBSEFischer Medical Ventures LtdHighNeutral
Announced Wed, 1 Apr · 15:19 IST

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shankar Varadharajan & PACs

Promoter Stake BuyOwnership Changes View source PDF

FISCHER · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.7%1-day move
₹40.31
prior close
₹41.19
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2-0.2+1.7+1.6+0.7+1.7+2.6+0.3-7.7-5.9-10.1+1.3
Up moveDown movePending
AI summary

Promoter Mr. Shankar Varadharajan, along with PACs FMV Holdings Pte Ltd and Mr. Ravindran Govindan, acquired 60,00,000 equity shares of Fischer Medical Ventures Ltd through preferential allotment upon conversion of warrants on 31 March 2026. This raised Shankar's direct holding from 10.64% (6.90 crore shares) to 11.46% (7.50 crore shares), while FMV Holdings Pte Ltd's holding stood at 50.69% (33.18 crore shares). The promoter group's combined holding (equity plus warrants) moved from 61.80% to 62.15% of total share capital, now also counting 1.10 crore warrants held by Shankar and 2.30 crore warrants held by FMV Holdings. Total equity capital of the company increased from 64.85 crore to 65.45 crore shares of Re. 1 each as a result of the allotment.

Likely market impact

This is a promoter-led acquisition via warrant conversion, signalling continued promoter confidence in the company. Shankar's personal stake grew while the overall promoter group holding strengthened, which is broadly viewed as a positive signal for shareholders. No shares were sold or pledged.